Position in ONCY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$37,811
+$4,460 QoQ
Shares Held
44,484
+16.0% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ONCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $701,516,965 across 82 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
427,448 | $212,326,240 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
942,432 | $73,764,150 | |
| 3 | ARGX |
Argenx SE
|
77,213 | $71,635,902 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
103,247 | $64,378,631 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
242,063 | $58,329,919 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
515,981 | $28,347,995 | |
| 7 | MRNA |
Moderna, Inc.
|
389,789 | $27,296,921 | |
| 8 | CYTK |
Cytokinetics Inc
|
285,688 | $24,337,759 |
All Filings in ONCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,811 | 44,484 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $33,351 | 38,336 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $53,495 | 38,211 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $29,826 | 38,736 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $21,541 | 39,168 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $35,699 | 39,231 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $32,993 | 37,924 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $37,050 | 37,425 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $39,558 | 37,320 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $50,735 | 37,582 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $71,165 | 32,645 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $84,187 | 32,380 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $41,407 | 34,506 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $60,082 | 36,861 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $45,338 | 36,861 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $33,046 | 32,720 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $56,437 | 35,720 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $42,412 | 30,513 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $22,009 | 10,531 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $45,593 | 16,460 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $44,763 | 11,749 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $32,678 | 13,731 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $16,305 | 9,649 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $12,413 | 6,603 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $9,691 | 7,023 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||